December 7, 2022 – Kainomyx, Top 5 out of 139 Global Startup Companies Tackling Malaria - US-based startup Kainomyx offers small molecule therapeutics for neglected tropical diseases, with a focus on malaria. The startup’s proprietary platform combines parasite biology with biochemical and biophysical approaches to target pivot components of parasites. It targets cytoskeletal proteins of parasites to advance drug development and offers tests to identify asymptomatic carriers. Kainomyx’s solutions aid in the treatment of parasitic tropical diseases and facilitate early case detection to devise appropriate control measures in endemic situations.  

5 Top HealthTech Startups tackling Malaria | StartUs Insights (startus-insights.com)